title: Planning for financial impact of antiendotoxin monoclonal antibodies.
authors.forename: G
authors.initials: G
authors.lastname: Bailey
authors.forename: J W
authors.initials: JW
authors.lastname: Denman
authors.forename: T
authors.initials: T
authors.lastname: Killilea
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016527:Drug Costs; D005377:Financial Management, Hospital / Q000191:economics; D006780:Hospitals, Rural / Q000191:economics; D006801:Humans; D007075:Immunoglobulin M
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C068069:nebacumab